Biaryl Compounds as Dihydroorotate Dehydrogenase Inhibitors for Treating Acute Myelogenous Leukemia (AML).

Published in: ACS medicinal chemistry letters (2022)

Keyphrases

acute myeloid leukemia
liver failure
respiratory failure
bone marrow
aortic dissection
drug induced
allogeneic hematopoietic stem cell transplantation
hepatitis b virus
intensive care unit
acute lymphoblastic leukemia
mechanical ventilation